ActoMeg Tablet 15 mg + 500 mg is a combination oral antidiabetic medication formulated to improve blood glucose control in patients with type 2 diabetes mellitus. Each tablet contains Pioglitazone 15 mg and Metformin Hydrochloride 500 mg, two well-established agents that work together to address insulin resistance and excessive glucose production. This dual-action formula supports effective glycemic management when lifestyle measures alone or single-drug therapy are not sufficient.

ActoMeg is intended to be used alongside a balanced diet, regular physical activity, and routine monitoring of blood glucose levels to achieve optimal diabetes control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Pioglitazone 15 mg

• Metformin Hydrochloride 500 mg

How It Works

ActoMeg combines two complementary mechanisms to manage blood sugar levels:

Pioglitazone
Pioglitazone belongs to the thiazolidinedione class. It improves insulin sensitivity by activating specific receptors (PPAR-gamma) in fat and muscle tissues. This helps the body use insulin more effectively, reducing insulin resistance and lowering blood glucose levels.

Metformin Hydrochloride
Metformin is a biguanide that primarily reduces glucose production by the liver (hepatic gluconeogenesis). It also enhances peripheral glucose uptake and improves insulin sensitivity without stimulating excessive insulin release. This helps control fasting and post-meal blood sugar levels while minimizing the risk of hypoglycemia when used alone.

Indications

ActoMeg Tablet 15 mg + 500 mg is indicated for:

• Management of Type 2 Diabetes Mellitus

• Patients inadequately controlled with metformin alone

• Patients who require combination therapy for better glycemic control

• As part of a comprehensive diabetes treatment plan including diet and exercise

Benefits

• Dual Mechanism of Action: Targets both insulin resistance and excessive glucose production.

• Improved HbA1c Levels: Helps reduce long-term blood glucose indicators.

• Reduced Risk of Hypoglycemia: Lower risk compared to insulin or sulfonylureas when used appropriately.

• Convenient Combination: Two medications in one tablet improve treatment adherence.

• Metabolic Support: May contribute to better lipid profile control under medical supervision.

Dosage and Administration

The dosage of ActoMeg should be determined by a healthcare professional based on the patient’s glycemic status and response to treatment. It is usually taken once or twice daily with meals to reduce gastrointestinal side effects associated with metformin.

Patients should follow their doctor’s instructions carefully and undergo regular blood glucose and HbA1c monitoring to evaluate treatment effectiveness.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

• Not recommended for Type 1 diabetes or diabetic ketoacidosis.

• Use with caution in patients with renal or hepatic impairment.

• Pioglitazone may cause fluid retention, so caution is advised in patients with heart failure.

• Metformin may cause mild gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort, especially at the start of therapy.

• Regular monitoring of kidney and liver function is advised during treatment.

Patients should inform their healthcare provider about all other medications and existing medical conditions before starting ActoMeg.